← Browse by Condition
Medical Condition
peripheral t cell lymphoma
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT04984837 Phase 2
Recruiting
Study of Lacutamab in Peripheral T-cell Lymphoma
Enrollment
56 pts
Location
Belgium, France, Ger...
Sponsor
The Lymphoma Academic Research...
NCT06914037 Phase 1
Recruiting
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
Enrollment
24 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT05675813 Phase 1, Phase 2
Recruiting
Genotype-guided Treatment in Newly Diagnosed PTCL
Enrollment
264 pts
Location
China
Sponsor
Ruijin Hospital
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT04390737 Phase 1, Phase 2
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Enrollment
254 pts
Location
United States, China
Sponsor
Haihe Biopharma Co., Ltd.
NCT07356245 Phase 2
Recruiting
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Enrollment
44 pts
Location
United States
Sponsor
Jonathan Brammer
NCT06509945
Recruiting
Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL
Enrollment
50 pts
Location
China
Sponsor
Shanghai General Hospital, Sha...
NCT06468267 Phase 2
Recruiting
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
Enrollment
50 pts
Location
China
Sponsor
Xianmin Song, MD
NCT07283822 Phase 2
Recruiting
Amping up With PemJAK
Enrollment
53 pts
Location
United States
Sponsor
Seda S. Tolu
NCT06244368 Phase 2
Recruiting
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Enrollment
115 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT07389616 Phase 2, Phase 3
Recruiting
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Enrollment
40 pts
Location
China
Sponsor
Shanghai General Hospital, Sha...